A retrospective medical chart review of the use of omalizumab in chronic idiopathic urticaria - 21/04/16
Joshua Clark, University of Utah, Department of Dermatology, Salt Lake City, UT, United States; Aaron Secrest, MD, PhD, University of Utah, Department of Dermatology, Salt Lake City, UT, United States; Christopher Hull, MD, University of Utah, Department of Dermatology, Salt Lake City, UT, United States; Mark Eliason, MD, University of Utah, Department of Dermatology, Salt Lake City, UT, United States; Kristin Leiferman, MD, University of Utah, Department of Dermatology, Salt Lake City, UT, United States; Gerald Gleich, MD, University of Utah, Department of Dermatology, Salt Lake City, UT, United States; Douglas Powell, MD, University of Utah, Department of Dermatology, Salt Lake City, UT, United States
Le texte complet de cet article est disponible en PDF. Commercial support: None identified. |
Vol 74 - N° 5S1
P. AB142 - mai 2016 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?